Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 12/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | SPHK1 | Q9NYA1 | 3/20 | 0.42 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.42 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.42 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dodine SCHEMBL10981167 | 0.90 | FAAH (0.51) | FAAHACHEEPHX2ALDH1A1SPHK1 | |
| SCHEMBL6410426 | 0.88 | FAAH (0.45) | FAAHACHEALDH1A1 | |
| SCHEMBL6415654 | 0.88 | FAAH (0.45) | FAAHACHEALDH1A1 | |
| SCHEMBL6408519 | 0.87 | ALDH1A1 (0.45) | FAAHACHEALDH1A1 | |
| SCHEMBL20542788 | 0.82 | ACHE (0.70) | ACHEEPHX2 | |
| Tetradecanamide SCHEMBL5182998 | 0.82 | FAAH (0.47) | FAAHALDH1A1SPHK1 | |
| Palmitamide SCHEMBL5180724 | 0.82 | FAAH (0.47) | FAAHALDH1A1SPHK1 | |
| Acetic Acid SCHEMBL6696904 | 0.82 | FAAH (0.47) | FAAHALDH1A1SPHK1 | |
| SCHEMBL6408896 | 0.82 | ALDH1A1 (0.47) | FAAHACHEALDH1A1 | |
| Hydrochloric Acid SCHEMBL20542698 | 0.81 | ACHE (0.68) | ACHEEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1285579-B1 | Bactericidal guanidine derivatives, dermally applicable composition, washing composition, and antibacterial fibre aggregate | AJINOMOTO KK (JP) | 2005-11-02 | — | — | EP | disclosed |
| US-20030162838-A1 | Bactericide, antiseptic, dermally applicable composition, washing composition, antibacterial fiber aggregate, method for eradicating a microorganism, and method for inhibiting the proliferation of a microorgamism | AJINOMOTO CO., INC. (JP) | 2003-08-28 | — | — | US | disclosed |
| EP-1285579-A1 | Bactericidal guanidine derivatives, dermally applicable composition, washing composition, and antibacterial fibre aggregate | Ajinomoto Co., Inc. (JP) | 2003-02-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030162838-A1 | Bactericide, antiseptic, dermally applicable composition, washing composition, antibacterial fiber aggregate, method for eradicating a microorganism, and method for inhibiting the proliferation of a microorgamism | ARG1, ALKBH1, GANC | FAAH 682/4885ACHE 293/4885EPHX2 4570/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.